InvestorsHub Logo

leifsmith

11/08/13 8:32 AM

#76303 RE: another_voice_2 #76300

Sounds right to me.

ZincFinger

11/08/13 9:10 AM

#76304 RE: another_voice_2 #76300

I agree. Getting distracted with poor targets (even if additional money is given for them) can have bad results for an early biotech.

"First pick the low hanging fruit." Get revenues coming in and a sound financial foundation. THEN you can go after more challenging targets without incurring a high risk of bankruptcy should one or two fail.

Going for fruit too high on the tree right from the start is the overwhelming cause of failure of early biotechs.

The critical focus in the beginning should always be to prove the technology works with a simple easy target or two (and learn about the technology in the process.)

FORZANANO

11/08/13 11:51 AM

#76309 RE: another_voice_2 #76300

I completely get it!

Dr Seymour CEO of Nanoviricides
Top n 1 health company that is changing medicine and beating Google and Apple on the stock market!!!

Many CEO would want that position!

FN